Agios Pharmaceuticals (AGIO) Short Interest Ratio & Short Volume → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free AGIO Stock Alerts $34.54 -0.04 (-0.12%) (As of 05/3/2024 08:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Agios Pharmaceuticals Short Interest DataCurrent Short Volume6,650,000 sharesPrevious Short Volume6,600,000 sharesChange Vs. Previous Month+0.76%Dollar Volume Sold Short$194.58 millionShort Interest Ratio / Days to Cover8.9Last Record DateApril 15, 2024Outstanding Shares56,770,000 sharesFloat Size54,740,000 sharesShort Percent of Float12.15%Today's Trading Volume807,800 sharesAverage Trading Volume800,344 sharesToday's Volume Vs. Average101% Short Selling Agios Pharmaceuticals ? Sign up to receive the latest short interest report for Agios Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAGIO Short Interest Over TimeAGIO Days to Cover Over TimeAGIO Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Agios Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,650,000 shares $194.58 million +0.8%12.2%8.9 $29.26 3/31/20246,600,000 shares $192.98 million -3.7%12.1%8.3 $29.24 3/15/20246,850,000 shares $205.09 million -6.6%12.5%8.3 $29.94 2/29/20247,330,000 shares $236.91 million -4.2%13.4%8.8 $32.32 2/15/20247,650,000 shares $205.02 million +4.2%14.0%10 $26.80 1/31/20247,340,000 shares $166.03 million -8.6%13.4%11.3 $22.62 Get the Latest News and Ratings for AGIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,030,000 shares $182.60 million +13.1%14.7%11.5 $22.74 12/31/20237,100,000 shares $158.12 million +3.4%13.0%10.9 $22.27 12/15/20236,870,000 shares $159.66 million +7.2%12.5%11.6 $23.24 11/30/20236,410,000 shares $142.49 million +6.5%11.7%11.7 $22.23 11/15/20236,020,000 shares $135.27 million +6.4%11.0%11.3 $22.47 10/31/20235,660,000 shares $118.92 million +2.5%10.6%11.2 $21.01 10/15/20235,520,000 shares $127.62 million -5.5%10.3%13.3 $23.12 9/30/20235,840,000 shares $144.54 million -3.5%10.9%15.3 $24.75 9/15/20236,050,000 shares $157.84 million +2.5%11.3%16.6 $26.09 8/31/20235,900,000 shares $161.84 million -1.0%11.0%15.2 $27.43 8/15/20235,960,000 shares $165.39 million -1.5%11.2%14.4 $27.75 7/31/20236,050,000 shares $160.45 million -2.9%11.3%14.1 $26.52 7/15/20236,230,000 shares $169.58 million +5.4%11.7%13.4 $27.22 6/30/20235,910,000 shares $167.37 million +2.4%11.1%12.7 $28.32 6/15/20235,770,000 shares $148.92 million +0.5%10.8%12.2 $25.81 5/31/20235,740,000 shares $145.11 million -0.9%10.8%12.1 $25.28 5/15/20235,790,000 shares $151.70 million +1.6%10.9%11.3 $26.20 4/30/20235,700,000 shares $130.36 million +6.3%10.7%10.8 $22.87 4/15/20235,360,000 shares $117.60 million -6.9%10.1%10 $21.94 3/31/20235,760,000 shares $132.31 million -3.2%10.9%10.8 $22.97 3/15/20235,950,000 shares $140.60 million +1.2%11.2%11.4 $23.63 2/28/20235,880,000 shares $148.82 million +1.7%11.1%11.4 $25.31 2/15/20235,780,000 shares $160.16 million +0.2%11.0%11.9 $27.71 1/31/20235,770,000 shares $170.10 million -13.8%10.9%12.1 $29.48 1/15/20236,690,000 shares $199.16 million -1.2%12.7%13.5 $29.77 12/30/20226,770,000 shares $190.10 million +2.1%12.8%14.3 $28.08 12/15/20226,630,000 shares $196.98 million +4.1%12.6%13 $29.71 11/30/20226,370,000 shares $191.99 million +1.0%12.1%11.2 $30.14 11/15/20226,310,000 shares $179.27 million -1.1%12.0%9.4 $28.41 10/31/20226,380,000 shares $175.71 million +7.4%12.1%9.2 $27.54 10/15/20225,940,000 shares $160.20 million +6.6%11.3%8.1 $26.97 9/30/20225,570,000 shares $157.52 million -1.9%10.6%7.6 $28.28 9/15/20225,680,000 shares $193.57 million +3.3%10.5%7.5 $34.08 8/31/20225,500,000 shares $140.25 million -11.0%10.2%6.9 $25.50The asset beating inflation by 4x (Ad)"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details AGIO Short Interest - Frequently Asked Questions What is Agios Pharmaceuticals' current short interest? Short interest is the volume of Agios Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 6,650,000 shares of AGIO short. 12.15% of Agios Pharmaceuticals' shares are currently sold short. Learn More on Agios Pharmaceuticals' current short interest. What is a good short interest ratio for Agios Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGIO shares currently have a short interest ratio of 9.0. Learn More on Agios Pharmaceuticals's short interest ratio. Which institutional investors are shorting Agios Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Agios Pharmaceuticals: Concourse Financial Group Securities Inc., Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Agios Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.15% of Agios Pharmaceuticals' floating shares are currently sold short. Is Agios Pharmaceuticals' short interest increasing or decreasing? Agios Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 6,650,000 shares, an increase of 0.8% from the previous total of 6,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Agios Pharmaceuticals' float size? Agios Pharmaceuticals currently has issued a total of 56,770,000 shares. Some of Agios Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Agios Pharmaceuticals currently has a public float of 54,740,000 shares. How does Agios Pharmaceuticals' short interest compare to its competitors? 12.15% of Agios Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Agios Pharmaceuticals: Structure Therapeutics Inc. (9.92%), Evotec SE (0.02%), Syndax Pharmaceuticals, Inc. (11.30%), Amneal Pharmaceuticals, Inc. (2.51%), Galapagos NV (2.30%), Catalyst Pharmaceuticals, Inc. (6.18%), Schrödinger, Inc. (8.88%), Harmony Biosciences Holdings, Inc. (21.01%), Avidity Biosciences, Inc. (11.15%), NewAmsterdam Pharma (0.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Agios Pharmaceuticals stock? Short selling AGIO is an investing strategy that aims to generate trading profit from Agios Pharmaceuticals as its price is falling. AGIO shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Agios Pharmaceuticals? A short squeeze for Agios Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGIO, which in turn drives the price of the stock up even further. How often is Agios Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: GPCR Short Interest Data EVO Short Interest Data SNDX Short Interest Data AMRX Short Interest Data GLPG Short Interest Data CPRX Short Interest Data SDGR Short Interest Data HRMY Short Interest Data RNA Short Interest Data NAMS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AGIO) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance Gold41 banks launch ‘crypto dollar’Stansberry ResearchDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmith